Advancing the Future of Healing
Our team is proud to contribute to studies advancing the science of regenerative medicine and demonstrating the life-changing impact of birth tissue.
From restoring vision to healing burns, the applications are growing every year.
Case Study
For clinicians, researchers, and patients, this case study highlights the emerging potential of immune-modulating stem cell therapies in treating complex autoimmune diseases.
Published in the International Journal of Molecular Sciences, the article documents clinical, radiographic, and pathological improvements in a patient with long-standing Crohn’s disease following Stem Cell Educator therapy developed by Throne Biotechnologies.
The study includes contributions from Terri Tibbot, CEO of Life Line Stem Cell, underscoring Life Line’s active role in advancing clinical research. Using cord blood–derived stem cells to recalibrate immune response, the therapy was associated with marked reductions in inflammatory markers and sustained symptom improvement. While based on a single patient, the findings add to a growing body of research exploring novel, non-pharmaceutical approaches to autoimmune disease.
Further Reading
For expectant parents, healthcare leaders, and researchers, this article reveals why perinatal tissue donation is quickly becoming one of the most closely watched frontiers in modern medicine.
A Reuters investigation highlights how companies like Throne Biotechnologies are advancing regenerative medicine by studying placental and other perinatal tissues once routinely discarded after birth.
The piece explores how scientific innovation, ethical sourcing, and growing clinical demand are reshaping how these tissues are valued—underscoring their expanding role in research, healing, and future therapies.